Cubist Systematic Strategies, LLC Humacyte, Inc. Transaction History

Cubist Systematic Strategies, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$2.02 - $3.62 $44,068 - $78,973	21,816 New	21,816 $46,000
Q2 2022 Aug 15, 2022	SELL	$3.21 - $7.86 $92,367 - $226,171	-28,775 Reduced 59.61%	19,500 $63,000
Q1 2022 May 16, 2022	SELL	$4.65 - $7.4 $211,621 - $336,774	-45,510 Reduced 48.53%	48,275 $341,000
Q4 2021 Feb 14, 2022	BUY	$7.25 - $11.6 $679,941 - $1.09 Million	93,785 New	93,785 $680,000

172

41M

553K

942K

Ticker HUMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,007,000
Market Cap $365M
Description
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.